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Abstract 
Background Aldose reductase (AR) is the first enzyme in the polyol pathway that has 
been shown to play important roles in the pathogenesis of diabetic complications such 
as diabetic neuropathy and diabetic retinopathy. Previous studies regarding AR’s roles 
in diabetic nephropathy, however, remain inconclusive, partly due to the specificity 
and the potential side effects of chemical inhibitors for AR. In our current 
investigations, we utilized genetically-manipulated mouse models that are deficient 
for AR to study the effects of AR deficiency on the progression of diabetic 
nephropathy. 
Methodology Three genotype groups of eight-week old male C57BL/6 mice were 
used in the study. They included the wild-type mice (WT), the AR knockout mice 
(KO) and a bitransgenic line of mice (BT) that are deficient for AR in most tissues 
except the kidney medulla epithelial cells where a transgene expresses AR locally in 
the collecting tubule epithelial cells.. Mice were treated with streptozotocin by 
intraperitoneal injection (40 mg· kg-1·day-1 for 5 days) to induce hyperglycemia. A 
number of parameters for renal functional and histopathological changes for 25-week 
old diabetic and nondiabetic control mice were assayed.  
Results In comparison with the diabetic WT mice, both the diabetic KO and BT mice 
had lower levels of diabetes-induced extracellular matrix accumulation and 
glomerular hypertrophy. Moreover, diabetic KO and BT mice also had lower levels of 
urinary albumin, urinary protein, serum triglycerides and LDL-c than the diabetic WT 
mice. Additionally, blood urea nitrogen (BUN) and glomerular filtration rate (GFR) 
and serum cholesterol were significantly improved in diabetic BT but less so for the 
diabetic KO mice. In renal cortex, diabetic KO and BT mice exhibited lower protein 
expression of type IV collagen and transforming growth factor-β1 as determined by 
immunohistochemical staining and Western blots. In comparison with the diabetic 















the membrane fraction but higher in the cytosolic fraction for diabetic BT mice.  
Conclusion Collectively, these results demonstrated that genetic AR deficiency led to 
significant improvement in the progression of diabetic nephropathy. It suggests that 
AR indeed contributes to the pathogenesis of diabetic nephropathy in vivo and that 
AR inhibition might be beneficial for the prevention/treatment of this diabetic 
complication. 
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缩略语对照表 
缩略语 英文 中文 
NAD Nicotinamide adenine dinucleotide 烟酰胺腺嘌呤二核苷酸 
DAB 3，3‘-Diaminobenaidioe 二氨基联苯胺 
ECM Extracellular matrix 细胞外基质 
EDTA Ethylene diaminetetrasetie acid 乙二胺四乙酸 
HDL High density lipoprotein 高密度脂蛋白 
LDL Low density lipoprotein 低密度脂蛋白 
MAPK Mitogen activated protein kinases 丝裂素活化的蛋白激酶 
mRNA Messenger ribonueleie acid 信使核糖核酸 
PAS Periodic acid schiff 过碘酸一雪夫 
PBS Phosphate buffered saline 磷酸盐缓冲液 




















糖尿病可分为 I 型、II 型、妊娠糖尿病以及其他特殊类型糖尿病 4 种。其中 I 型
糖尿病即胰岛素依赖性糖尿病（IDDM），多发生于青幼年，又叫青年发病型糖
尿病，占糖尿病的 10%以下。由于 I 型糖尿病患者体内胰腺产生胰岛素的细胞已
经彻底损坏，从而完全失去了产生胰岛素的功能，所以必须依赖外源性胰岛素补
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DN 指糖尿病性肾小球硬化症，一种以血管损害为主的肾小球病变，是糖尿
病中 重要的微血管慢性并发症之一[10, 11]。其发病率约占糖尿病患者的 30%～
40%。国内发病率为 0.9%～36%。DN 已成为终末期肾病中首要的原因。DN 的
早期改变包括肾小球的高滤过状态、肾小球和肾小管上皮细胞肥大和出现微量白
蛋白尿。随后是肾小球基底膜增厚、系膜基质沉积和明显的蛋白尿， 后导致肾
小球硬化和终末期 DN。目前认为 DN 的发病机制与糖代谢紊乱、脂代谢紊乱、
高血压所致肾脏血流动力学改变、氧化应激、多种细胞因子及遗传背景有关。 
2.1 导致 DN 发生的途径 
2.1.1 糖代谢紊乱 
高血糖是导致糖尿病一系列代谢紊乱的根源，是DN的主要发病因素[12]。体
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